Back
Adaptive Biotechnologies Stock Predictions
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
ADPT
Adaptive Biotechnologies
Last Price:
$7.52
Seasonality Move:
11.6%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Adaptive Biotechnologies Stock Forecast
-
Over the next 52 weeks, Adaptive Biotechnologies has on average historically risen by 8.1% based on the past 5 years of stock performance.
-
Adaptive Biotechnologies has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Adaptive Biotechnologies Stock Undervalued?The current Adaptive Biotechnologies [ADPT] share price is $7.49. The Score for ADPT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
ADPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Adaptive Biotechnologies Stock Go Up Next Year?
-
Over the next 52 weeks, Adaptive Biotechnologies has on average historically risen by 8.1% based on the past 5 years of stock performance.
Adaptive Biotechnologies Stock Rating
Sell
30
Adaptive Biotechnologies (ADPT)
is a Sell
Is Adaptive Biotechnologies overpriced?
-
Adaptive Biotechnologies has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Adaptive Biotechnologies Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
adaptivebiotech.com
52-Week Data
52-Week High:
9.01
52-Week Low:
2.28
Prediction Charts
Market Cap:
1.1B
Price in USD:
7.49
Volume:
860K
Beta:
1.39
Technical Analysis
SMA50:
7.89
SMA100:
7.17
SMA200:
5.88
52-Wk Change:
172.36%
Stock Predictions
-
Is Adaptive Biotechnologies stock public?Yes, Adaptive Biotechnologies is a publicly traded company.
-
What is the Adaptive Biotechnologies stock quote today?The Adaptive Biotechnologies stock price is 7.49 USD today.
-
How to buy Adaptive Biotechnologies stock online?You can buy Adaptive Biotechnologies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-28 | 8.22 | 7.67 | 8.24 | 7.50 |
| Mar-31 | 7.27 | 7.43 | 7.68 | 7.11 |
| Apr-1 | 7.35 | 7.52 | 7.63 | 7.13 |
| Apr-2 | 7.38 | 7.94 | 8.04 | 7.30 |
| Apr-3 | 7.36 | 7.41 | 8.07 | 7.36 |
| Apr-4 | 7.10 | 7.47 | 7.62 | 6.68 |
| Apr-7 | 6.86 | 7.71 | 8.14 | 6.71 |
| Apr-8 | 8.08 | 7.67 | 8.49 | 7.44 |
| Apr-9 | 7.37 | 8.38 | 8.61 | 7.30 |
| Apr-10 | 8.13 | 7.73 | 8.14 | 7.52 |
| Apr-11 | 7.61 | 7.94 | 8.30 | 7.38 |
| Apr-14 | 8.10 | 7.82 | 8.20 | 7.64 |
| Apr-15 | 7.78 | 7.74 | 8.01 | 7.61 |
| Apr-16 | 7.63 | 7.49 | 7.73 | 7.30 |
Adaptive Biotechnologies Earnings
Adaptive Biotechnologies Earnings Report: Per Share Adaptive Biotechnologies Earnings Q1 Q2 Q3 and Q4 last year and next year.
Adaptive Biotechnologies Forecast Revenue Growth
Adaptive Biotechnologies Stock Analysis: Historical quarterly revenues per share for Adaptive Biotechnologies and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.19 per share, and an increase next year of $0.27 per share.
* Adaptive Biotechnologies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.